Researchers have developed antibodies that can bind to phosphohistidine, an unstable molecule that's linked to cancer. To learn how the two bind together, the team turned to the powerful X-rays at Argonne's Advanced Photon Source. These new insights into its structure will help scientists design better antibodies for potential treatments.